Gsk Plc Stock Price on December 12, 2024
GLAXF Stock | USD 16.83 0.21 1.23% |
If you're considering investing in GSK Pink Sheet, it is important to understand the factors that can impact its price. As of today, the current price of GSK Plc stands at 16.83, as last reported on the 14th of December 2024, with the highest price reaching 16.87 and the lowest price hitting 16.18 during the day. GSK plc holds Efficiency (Sharpe) Ratio of -0.12, which attests that the entity had a -0.12% return per unit of risk over the last 3 months. GSK plc exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out GSK Plc's Risk Adjusted Performance of (0.08), coefficient of variation of (842.94), and Market Risk Adjusted Performance of (2.18) to validate the risk estimate we provide.
GSK Pink Sheet price history is provided at the adjusted basis, taking into account all of the recent filings.
GSK |
Sharpe Ratio = -0.1212
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | GLAXF |
Estimated Market Risk
2.81 actual daily | 25 75% of assets are more volatile |
Expected Return
-0.34 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.12 actual daily | 0 Most of other assets perform better |
Based on monthly moving average GSK Plc is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of GSK Plc by adding GSK Plc to a well-diversified portfolio.
Related Headline
Pfizer Headline on 12th of December 2024
Pfizer Increases Quarterly Dividend by 2.4 by gurufocus.com
Pfizer Inc. , a leading pharmaceutical company, announced an increase in its quarterly dividend by 2.4, raising it from 0.42 to 0.43 per share. The new
GSK Plc Valuation on December 12, 2024
It is possible to determine the worth of GSK Plc on a given historical date. On December 12, 2024 GSK was worth 16.1 at the beginning of the trading date compared to the closed value of 17.04. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of GSK Plc pink sheet. Still, in general, we apply an absolute valuation method to find GSK Plc's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of GSK Plc where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against GSK Plc's related companies.
Open | High | Low | Close | Volume | |
17.44 | 17.44 | 16.98 | 17.07 | 16,542 | |
12/12/2024 | 16.10 | 17.39 | 16.10 | 17.04 | 2,114 |
16.87 | 16.87 | 16.18 | 16.83 | 5,200 |
Backtest GSK Plc | | | GSK Plc History | | | GSK Plc Valuation | Previous | Next |
GSK Plc Trading Date Momentum on December 12, 2024
On December 13 2024 GSK plc was traded for 16.83 at the closing time. The highest daily price throughout the period was 16.87 and the lowest price was 16.18 . The daily volume was 5.2 K. The net trading volume on 12/13/2024 added to the next day price reduction. The overall trading delta to closing price of the next trading day was 1.23% . The overall trading delta to current closing price is 1.00% . |
GSK plc Fundamentals Correlations and Trends
By evaluating GSK Plc's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among GSK Plc's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. GSK financial account trend analysis is a perfect complement when working with valuation or volatility modules.About GSK Plc Pink Sheet history
GSK Plc investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for GSK is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in GSK plc will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing GSK Plc stock prices may prove useful in developing a viable investing in GSK Plc
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom. Glaxosmithkline Plc is traded on OTC Exchange in the United States.
GSK Plc Pink Sheet Technical Analysis
GSK Plc technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
Price Boundaries
GSK Plc Period Price Range
Low | December 14, 2024
| High |
0.00 | 0.00 |
GSK plc cannot be verified against its exchange. Please verify the symbol is currently traded on PINK Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
GSK Plc December 14, 2024 Market Strength
Market strength indicators help investors to evaluate how GSK Plc pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading GSK Plc shares will generate the highest return on investment. By undertsting and applying GSK Plc pink sheet market strength indicators, traders can identify GSK plc entry and exit signals to maximize returns
GSK Plc Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for GSK Plc's price direction in advance. Along with the technical and fundamental analysis of GSK Pink Sheet historical price patterns, it is also worthwhile for investors to track various predictive indicators of GSK to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.08) | |||
Jensen Alpha | (0.35) | |||
Total Risk Alpha | (0.68) | |||
Treynor Ratio | (2.19) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Complementary Tools for GSK Pink Sheet analysis
When running GSK Plc's price analysis, check to measure GSK Plc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GSK Plc is operating at the current time. Most of GSK Plc's value examination focuses on studying past and present price action to predict the probability of GSK Plc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GSK Plc's price. Additionally, you may evaluate how the addition of GSK Plc to your portfolios can decrease your overall portfolio volatility.
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |